What Happened?
Cambridge, MA-based Repare-Therapeutics Appointed Daniel Durocher as Co Founder
About the Company
Repare Therapeutics is developing new, precision oncology drugs for patients that target specific vulnerabilities of tumor cells. Its approach integrates insights from several fields of cell biology including DNA repair and synthetic lethality. Repare`s platform combines a proprietary, high throughput, CRISPR‐enabled gene editing target discovery method with high‐resolution protein crystallography, computational biology and clinical informatics.
About the Person
Daniel Durocher is Co Founder at Repare Therapeutics. Previously, Daniel held various senior HR leadership roles in the industry.
Info Source
News
Short Profile